Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) Interest & Investment Income (2016 - 2026)

Achieve Life Sciences (ACHV) has disclosed Interest & Investment Income for 17 consecutive years, with $297000.0 as the latest value for Q1 2026.

  • Quarterly Interest & Investment Income fell 7.76% to $297000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Mar 2026, down 36.36% year-over-year, with the annual reading at $1.5 million for FY2025, 36.54% down from the prior year.
  • Interest & Investment Income for Q1 2026 was $297000.0 at Achieve Life Sciences, down from $427000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $833000.0 in Q2 2024, with the low at $4000.0 in Q1 2022.
  • Average Interest & Investment Income over 5 years is $304235.3, with a median of $262000.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income soared 4725.0% in 2023, then crashed 76.95% in 2025.
  • Achieve Life Sciences' Interest & Investment Income stood at $118000.0 in 2022, then skyrocketed by 76.27% to $208000.0 in 2023, then skyrocketed by 131.73% to $482000.0 in 2024, then fell by 11.41% to $427000.0 in 2025, then plummeted by 30.44% to $297000.0 in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Interest & Investment Income are $297000.0 (Q1 2026), $427000.0 (Q4 2025), and $554000.0 (Q3 2025).